辰欣药业股份有限公司2025年第二次临时股东大会决议公告

Meeting Overview - The second extraordinary general meeting of shareholders was held on September 16, 2025, at the company's office in Jining, Shandong Province [2] - The meeting was convened by the board of directors and chaired by Chairman Du Zhenxin, utilizing a combination of on-site and online voting methods [2][3] Attendance and Voting - All current directors (9) and supervisors (3) attended the meeting, along with the board secretary and other senior management [3][4] - No resolutions were rejected during the meeting [2] Resolutions Passed - The following key resolutions were approved: - Amendments to the Articles of Association and its attachments [3] - Amendments to the Rules of Procedure for Shareholders' Meetings [3] - Amendments to the Rules of Procedure for Board Meetings [4] - Amendments to the Independent Director Work System [4] - Establishment of Implementation Details for Cumulative Voting System [4] - Amendments to the Decision-Making System for External Guarantees [4] - Amendments to the Management System for the Appointment of Accounting Firms [4] - Establishment of the Compensation Management System for Directors and Senior Management [4] - Establishment of Behavior Norms for Controlling Shareholders and Actual Controllers [4] - Amendments to the Related Party Transaction Decision-Making System [5] - Amendments to the Fundraising Management Measures [5] - Abolishment of the Rules of Procedure for Supervisory Meetings [5] - Resolution to abolish the supervisory board and supervisors [5] - Resolution to permanently supplement remaining funds from fundraising projects into working capital [5] Legal Verification - The meeting was witnessed by lawyers from Shandong Guoyao Qindao (Jinan) Law Firm, confirming that the meeting's procedures complied with relevant laws and regulations [6] - The legal opinion concluded that the qualifications of the convenor and attendees were valid, and the voting procedures and results were lawful and effective [6]